Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions and methods for stimulating H.sub.3 histamine receptors

Pharmaceutical compositions and methods for stimulating H.sub.3 histamine receptors

US Patent 4767778 · Granted Aug 30, 1988

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the 2022
Therapeutical use of H3-ligands2021
Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical composi2021
Combination of adrenalin with an antidepressant for use in the treatment of shoc2021
Form of administration of enkephalinase inhibitor2016
Piperidinyl monocarboxylic acids as S1P1 receptor agonists2016
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 recep2016
(Aza)benzhydryl ether derivatives, their process of preparation and their use as2016
Benzazole derivatives as histamine H4 receptor ligands2015